MR-guided focused ultrasound: A new generation treatment of Parkinson's disease, essential tremor and neuropathic pain

Interventional Neuroradiology

Volumn 20, Issue 3, 2014, Pages 275-282

  Dobrakowski, Pawel Piotr ^a   Machowska Majchrzak, Agnieszka Kamila ^a   Łabuz Roszak, Beata ^a   Majchrzak, Krzysztof Grzegorz ^a   Kluczewska, Ewa ^a   Pierzchała, Krystyna Barbara ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Essential tremor; MR guided focused ultrasound; Neuropathic pain; Parkinsonian tremor

Indexed keywords

ABLATION THERAPY; CHRONIC DISEASE; ESSENTIAL TREMOR; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; NEUROPATHIC PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; REVIEW; SAFETY; TREATMENT INDICATION; TREATMENT OUTCOME; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); ELECTROENCEPHALOGRAM; ELECTROENCEPHALOGRAPHY; EPILEPSY; EQUIPMENT DESIGN; GLIOBLASTOMA; GLOBUS PALLIDUS; HEAT TREATMENT; HIGH INTENSITY FOCUSED ULTRASOUND DEVICE; HISTORY OF MEDICINE; MAGNETIC RESONANCE IMAGING GUIDED FOCUSED ULTRASOUND; NON INVASIVE PROCEDURE; NONHUMAN; PAIN ASSESSMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); THALAMUS; ULTRASOUND TRANSDUCER; UNIFIED PARKINSON DISEASE RATING SCALE; VISUAL ANALOG SCALE;

ESSENTIAL TREMOR; MR-GUIDED FOCUSED ULTRASOUND; NEUROPATHIC PAIN; PARKINSONIAN TREMOR;

ESSENTIAL TREMOR; EVIDENCE-BASED MEDICINE; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; NEURALGIA; PARKINSON DISEASE; TREATMENT OUTCOME;

EID: 84904808148     PISSN: 15910199     EISSN: None     Source Type: Journal    
DOI: 10.15274/INR-2014-10033     Document Type: Review

References (37)

1. Moser D, Zadicario E, Schiff G, et al. Measurement of targeting accuracy in focused ultrasound functional neurosurgery. Neurosurg Focus. 2012; 32 (1): E2. doi: 10.3171/2011.10.FOCUS11246.
2. Hariharan P, Myers MR, Banerjee RK. HIFU procedures at moderate intensities-effect of large blood vessel. Phys. Med. Biol. 2007; 52: 3493-3513. doi: 10.1088/0031-9155/52/12/011. (Pubitemid 46830638)
3. Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys. 1984; 10 (6): 787-800. doi: 10.1016/0360-3016(84) 90379-1. (Pubitemid 14094055)
4. Corbett RJ,Laptook AR, Tollefsbol G, et al. Validation of a noninvasive method to measure brain temperature in vivo using 1H NMR spectroscopy. J Neurochem. 1995; 64 (3): 1224-1230. doi: 10.1046/j.1471-4159.1995.64031224.x.
5. Corbett R, Laptook AR, Weatherall P. Noninvasive measurements of human brain temperature using volume-localized proton magnetic resonance spectroscopy. J Cereb Blood Flow Metab. 1997; 17 (4): 363-369. doi: 10.1097/00004647- 199704000-00001. (Pubitemid 27188532)
6. Wood EW, Loomis AL. The physical and biological effects of high-frequency sound-waves of great intensity. Philos Mag. 1927; Series 7 (4): 417-436.
7. Lynn J, Zwemer R, Chick A, et al. A new method for the generation and use of focused ultrasound in experimental biology. J. Gen. Physiol. 1942; 26 (6): 179-193. doi: 10.1085/jgp.26.2.179.
8. Fry W, Barnard J, Fry F, et al. Ultrasonic lesions in the mammalian central nervous system. Science. 1942; 122: 517-518. doi: 10.1126/science.122. 3168.517.
9. Fry WJ, Mosberg WH, Barnard JW, et al. Production of focal destructive lesions in the central nervous system with ultrasound. J. Neurosurg. 1954; 11 (5): 471-478. doi: 10.3171/jns.1954.11.5.0471.
10. Meyers R, Fry WJ, Fry FJ, et al. Early experiences with ultrasonic irradiation of the pallidofugal and nigral complexes in hyperkinetic and hypertonic disorders. J Neurosurg. 1959; 16 (1): 32-54. doi: 10.3171/jns.1959.16.1.0032.
11. Vykhodtseva N, McDannold N, Martin H, et al. Apoptosis in ultrasound-produced threshold lesions in the rabbit brain. Ultrasound Med Biol. 2001; 27 (1): 111-117. doi: 10.1016/S0301-5629(00)00275-1. (Pubitemid 32280238)
12. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on tremor. Ad Hoc Scientific Committee. Mov Disord. 1998; 13 (suppl 3): 2-23. doi: 10.1002/mds.870131303. (Pubitemid 28517753)
13. Zesiewicz TA, Elble RJ, Louis ED, et al. Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology. 2011; 77 (19): 1752-1755. doi: 10.1212/WNL.0b013e318236f0fd.
14. Elias WJ, Huss D, Voss T, et al. A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med. 2013; 369 (7): 640-648. doi: 10.1056/NEJMoa1300962.
15. Lipsman N, Schwartz ML, Huang Y, et al. MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study. Lancet Neurol. 2013; 12 (5): 462-468. doi: 10.1016/S1474-4422(13)70048-6.
16. Horstink M, Tolosa E, Bonuccelli U, et al. European Federation of Neurological Societies; Movement Disorder Society-European Section. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society-European Section. Part I: early (uncomplicated) Parkinson's disease. Eur J Neurol. 2006; 13 (11): 1170-1185. doi: 10.1111/j.1468-1331.2006.01547.x. (Pubitemid 44581464)
17. Horstink M, Tolosa E, Bonuccelli U, et al. European Federation of Neurological Societies; Movement Disorder Society-European Section. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease. Eur J Neurol. 2006; 13 (11): 1186-1202. doi: 10.1111/j.1468-1331.2006.01548.x. (Pubitemid 44581465)
18. Ferreira JJ, Katzenschlager R, Bloem BR. et al. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol. 2013; 20 (1): 5-15. doi: 10.1111/j.1468-1331. 2012.03866.x.
19. Berardelli A, Wenning GK, Antonini A, et al. EFNS/MDS-ES/ENS corrected recommendations for the diagnosis of Parkinson's disease. Eur J Neurol. 2013; 20 (1): 16-34. doi: 10.1111/ene.12022.
20. Jeanmonod D, Moser D, Magara D, et al. Study on incisionless transcranial MR-guided focused ultrasound treatment of Parkinson's disease; safety accuracy and initial clinical outcomes. Current and future applications of focused ultrasound; 2012 Oct 14-17, Washington.
21. Consensus guidelines: treatment planning and options. Mayo Clin. Proc. 2006; 81 (suppl. 4): 12-25. doi: 10.1016/S0025-6196(11)61475-4.
22. Attal N, Gruccu G, Haanpaa M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur. J. Neurol. 2006; 13 (11): 1153-1169. doi: 10.1111/j.1468-1331.2006.01511.x. (Pubitemid 44581463)
23. Dworkin RH, O'Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010; 85 (Suppl): S3-14. doi: 10.4065/mcp.2009.0649.
24. Jeanmonod D, Magnin M, Morel A. Low-threshold calcium spike bursts in the human thalamus. Common physiopathology for sensory, motor and limbic positive symptoms. Brain. 1996; 119 (Pt 2): 363-375. doi: 10.1093/brain/119.2.363.
25. Sarnthein J, Stern J, Aufenberg C, et al. Increased EEG power and slowed dominant frequency in patients with neurogenic pain. Brain. 2006; 129 (Pt 1): 55-64. doi: 10.1093/brain/awh631. (Pubitemid 43063759)
26. Jeanmonod D, Magnin M, Morel A, et al. Surgical control of the human thalamocortical dysrhythmia: I. Central lateral thalamotomy in neurogenic pain. Thalamus & Related Systems. 2001; 1: 245-254. doi: 10.1016/S1472-9288(01) 00026-7.
27. Jeanmonod D, Werner B, Morel A, et al. Transcranial magnetic resonance imaging-guided focused ultrasound: noninvasive central lateral thalamotomy for chronic neuropathic pain. Neurosurg Focus. 2012; 32 (1): 1-11. doi: 10.3171/2011.10.FOCUS11248.
28. Hynynen K, McDannold N, Sheikov NA, et al. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage. 2005; 24 (1): 12-20. doi: 10.1016/j.neuroimage.2004.06.046. (Pubitemid 39611021)
29. McDannold N, Arvanitis CD, Vykhodtseva N, et al. Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. Cancer Res. 2012; 72 (14): 3652-3663. doi: 10.1158/0008-5472.CAN-12-0128.
30. Alkins R, Burgess A, Ganguly M, et al. Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res. 2013; 73 (6): 1892-1899. doi: 10.1158/0008-5472.CAN-12-2609.
31. Monteith SJ, Harnof S, Medel R, et al. Minimally invasive treatment of intracerebral hemorrhage with magnetic resonance-guided focused ultrasound. J Neurosurg. 2013; 118 (5): 1035-1045. doi: 10.3171/2012.12.JNS121095.
32. McDannold N, Clement GT, Black P, et al. Transcranial magnetic resonance imaging-guided focused ultrasound surgery of brain tumors: initial findings in 3 patients. Neurosurgery. 2010; 66 (2): 323-332. doi: 10.1227/01.NEU.0000360379. 95800.2F.
33. Boison D. The sound of noninvasive seizure control. Epilepsy Curr. 2011; 11 (6): 196-197. doi: 10.5698/1535-7511-11.6.196.
34. Bor-Seng-Shu E, Nogueira R de C, Figueiredo EG, et al. Sonothrombolysis for acute ischemic stroke: a systematic review of randomized controlled trials. Neurosurg Focus. 2012; 32 (1): E5. doi: 10.3171/2011.10.FOCUS11251.
35. Hölscher T, Fisher DJ, Raman R, et al. Noninvasive transcranial clot lysis using high intensity focused ultrasound. J Neurol Neurophysiol. 2011; S1. doi: 10.4172/2155-9562.S1-002.
36. Wright C, Hynynen K, Goertz D. In vitro and in vivo high-intensity focused ultrasound thrombolysis. Invest Radiol. 2012; 47 (4): 217-225. doi: 10.1097/RLI.0b013e31823cc75c.
37. Burgess A, Huang Y, Waspe AC, et al. High-intensity focused ultrasound (HIFU) for dissolution of clots in a rabbit model of embolic stroke. PLoS One. 2012; 7 (8): e42311. doi: 10.1371/journal.pone.0042311.